19 . March , 2018 - Monday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Orphenadrine injection

Big Image
Generic Name: Orphenadrine citrate
Dosage Form: Injection


Orphenadrine Description

Orphenadrine citrate is the citrate salt of Orphenadrine N,N-dimethyl-2-[(o-methyl-α-phenylbenzyl)oxy]-ethylamine citrate (1:1). It occurs as a white, crystalline powder having a bitter taste. It is practically odorless; sparingly soluble in water, slightly soluble in alcohol.

Each vial contains 60 mg of Orphenadrine citrate in aqueous solution. Each vial also contains: sodium metabisulfite, 2 mg; sodium chloride, 5.8 mg; sodium hydroxide, to adjust pH; and water for injection, q.s. to 2 mL. The structural formula is:

Molecular Formula: C18H23NO•C6H8O7 M.W.: 461.50

Orphenadrine - Clinical Pharmacology

The mode of therapeutic action has not been clearly identified, but may be related to its analgesic properties. Orphenadrine citrate also possesses anti-cholinergic actions.

Indications and Usage for Orphenadrine

Orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. The mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. Orphenadrine citrate does not directly relax tense skeletal muscles in man.


Contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis.

Contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.


Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine citrate may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.

Orphenadrine citrate injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than nonasthmatic people.


Confusion, anxiety and tremors have been reported in few patients receiving propoxyphene and Orphenadrine concomitantly. As these symptoms may be simply due to an additive effect, reduction of dosage and/or discontinuation of one or both agents is recommended in such cases.

Orphenadrine citrate should be used with caution in patients with tachycardia, cardiac decompensation, coronary insufficiency, cardiac arrhythmias.

Safety of continuous long-term therapy with Orphenadrine has not been established. Therefore, if Orphenadrine is prescribed for prolonged use, periodic monitoring of blood, urine and liver function values is recommended.


Teratogenic Effects; Pregnancy Category C

Safe use of Orphenadrine has not been established with respect to adverse effects upon fetal development. Therefore, Orphenadrine should be used in women of childbearing potential and particularly during early pregnancy only when in the judgment of the physician the potential benefits outweigh the possible hazards.

Pediatric Use

Safety and effectiveness in children have not been established; therefore, this drug is not recommended for use in the pediatric age group.

Adverse Reactions

Adverse reactions of Orphenadrine are mainly due to the mild anti-cholinergic action of Orphenadrine, and are usually associated with higher dosage. Dryness of the mouth is usually the first adverse effect to appear. When the daily dose is increased, possible adverse effects include: tachycardia, palpitation, urinary hesitancy or retention, blurred vision, dilatation of pupils, increased ocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, hypersensitivity reactions, pruritus, hallucinations, agitation, tremor, gastric irritation, and rarely urticaria and other dermatoses. Infrequently, an elderly patient may experience some degree of mental confusion. These adverse reactions can usually be eliminated by reduction in dosage. Very rare cases of aplastic anemia associated with the use of Orphenadrine tablets have been reported. No causal relationship has been established.

Rare instances of anaphylactic reaction have been reported associated with the intramuscular injection of Orphenadrine citrate.

Orphenadrine Dosage and Administration

Adults - One 2 mL vial (60 mg) intravenously or intramuscularly; may be repeated every 12 hours. Relief may be maintained by one (100 mg) Orphenadrine citrate tablet twice daily.

Parenteral drug products should be inspected visually for particulate matter, whenever solution and container permit.

How is Orphenadrine Supplied

Orphenadrine Citrate Injection USP is supplied as follows: Cartons of 10 (NDC 55390-059-10) 2 mL vials, each vial containing 60 mg of Orphenadrine citrate in aqueous solution.

Store at controlled room temperature 15° to 30°C (59° to 86°F). [See USP.] Protect from light.

Single dose vial. Discard unused portion.

Manufactured by:                                                 Manufactured for:

Ben Venue Laboratories, Inc.                                Bedford Laboratories™

Bedford, OH 44146                                               Bedford, OH 44146

September 2004                                                   Div - ORP - P01

Orphenadrine citrate (Orphenadrine citrate)
Product Code 55390-059 Dosage Form INJECTION
Route Of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Name (Active Moiety) Type Strength
Orphenadrine citrate (Orphenadrine) Active 60 MILLIGRAM  In 2 MILLILITER
sodium chloride Inactive  
sodium hydroxide Inactive  
sodium metabisulfite Inactive  
water Inactive  
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
# NDC Package Description Multilevel Packaging
1 55390-059-10 10 VIAL In 1 BOX contains a VIAL
1 2 MILLILITER In 1 VIAL This package is contained within the BOX (55390-059-10)

Revised: 10/2006

Recent Drug Updates at DrugIndexOnline:

Atromid-S Atromid-S
Generic Name: clofibrate (kloe FIB rate) Brand Names: Atromid-S What is Atromid-S (clofibrate)? Clofibrate is used to lower high levels of cholesterol (a type of fat) in the blood. Clofibrate is especially good at lowering triglycerides and very-low-density lipoprotein (VLDL) (a form of more...

Clonazepam Clonazepam
Generic Name: Clonazepam Tablets (kloe-NA-ze-pam) Brand Name: KlonopinClonazepam is used for:Controlling certain types of seizures in the treatment of epilepsy and for the treatment of panic disorders. It may also be used for other conditions as determined by your doctor. Clonazepam is a benzo more...

glyburide glyburide
Generic Name: glyburide (GLYE byoor ide) Brand Names: DiaBeta, Glynase PresTab, Micronase What is glyburide? Glyburide is in a class of drugs called sulfonylureas. It is used to help control blood sugar levels. Glyburide is used to treat type 2 diabetes along with diet, exercise, and ins more...

Humulin 10/90 Humulin 10/90
Some commonly used brand names are: In the U.S.— Humulin 50/50 14 Humulin 70/30 14 Humulin 70/30 Pen 14 Humulin L 10 Humulin N 13 Humulin N Pen 13 Humulin R 7 Humulin R, Regular U-500 (Concentrated) 7 Humulin U 5 Lente Iletin II 8 Lente 8 Novolin 70/30 14 Novolin L 10 Novolin N 13 Novolin more...

Laniroif Laniroif
Generic Name: aspirin/butalbital/caffeine (AS pir in/byoo TAL bi tall/CAF een) Brand Names: Fiorinal, Fiormor, Fiortal, Fortabs, Laniroif What is Laniroif (aspirin/butalbital/caffeine)? Aspirin is a pain reliever, as well as an anti-inflammatory and a fever reducer. Butalbital is in a c more...

Lorabid Lorabid
Generic name: Loracarbef Brand names: Lorabid Why is Lorabid prescribed? Lorabid is used to treat mild-to-moderate bacterial infections of the lungs, ears, throat, sinuses, skin, urinary tract, and kidneys. Most important fact about Lorabid If you have ever had an allergic reaction to Lorabid, more...

Lotensin Lotensin
Generic Name: benazepril (ben AY ze pril) Brand Names: Lotensin What is benazepril? Benazepril is in a group of drugs called ACE inhibitors. ACE stands for angiotensin converting enzyme. Benazepril is used to treat high blood pressure (hypertension). Benazepril may also be used for purp more...

Morphine Sustained-Release Tablets Morphine Sustained-Release Tablets
Generic Name: Morphine Sustained-Release Tablets (MORE-feen) Brand Name: Examples include MS Contin and Oramorph SRMorphine Sustained-Release Tablets is used for:Managing moderate to severe pain for more than a few days. Morphine Sustained-Release Tablets is a narcotic pain reliever. It works b more...